Figure 2.
Median prescribed intervals from infusion 2 (INF2) to INF3 and from INF3 to INF4 for the accelerated dosing (AD) vs the non-AD group.

Median prescribed intervals from infusion 2 (INF2) to INF3 and from INF3 to INF4 for the accelerated dosing (AD) vs the non-AD group.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close